Elicio Therapeutics, Inc. (ELTX)
(Delayed Data from NSDQ)
$4.85 USD
-0.05 (-1.02%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $4.78 -0.07 (-1.44%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Price, Consensus and EPS Surprise
ELTX 4.85 -0.05(-1.02%)
Will ELTX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ELTX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for ELTX
Elicio Therapeutics Announces Pricing of $11.5 Million Underwritten Public Offering
Why Is Elicio Therapeutics (ELTX) Stock Down 36% Today?
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Elicio Therapeutics Announces Proposed Public Offering
Elicio Therapeutics Announces Preliminary Disease-Free Survival analysis from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P